Alivexis
alivexis.com
Immunology & Inflammation Therapeutics
Oncology Therapeutics
Prescription Drugs
Drug Discovery
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
StartX, JIC Venture Growth Investments
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 2024
Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Himuka AM Pharma develops drug candidates derived from adrenomedullin (AM), a bioactive peptide originally discovered at the University of…
Mapping Biology to Precise Medicines The best therapeutics are built around the best targets. By analyzing massive datasets from individual…
We transform somatic genomics insights into potentially breakthrough medicines. Learn more at Quotient-Tx.com
Treeline Biosciences is a biotechnology company developing small-molecule medicines for cancer and immune diseases.
Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune…
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Overview
Alivexis is a technology-driven drug discovery company developing small-molecule therapeutics for oncology, chronic inflammation and immune disorders, and rare genetic diseases. The company integrates unique core biology insights with a supercomputer-powered discovery platform and scalable networked operations to advance its proprietary programs and collaborative projects. It operates offices in Tokyo and Boston and focuses on efficient delivery of breakthrough medicines for patients with unmet medical needs.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Keio Innovation InitiativeVia a fund
JIC Venture Growth InvestmentsVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely